3M Co. (NYSE:MMM) may have lost $1.3 million judgment in a long-running lawsuit over its BacLite diagnostic test, but the conglomerate is declaring victory anyway.
A U.K. judge ordered the Minneapolis-area company to pay the damages after finding that the company pulled the test, used to detect methicillin-resistant Staphylococcus aureus, for commercial reasons rather than for 3M’s claim that it pulled the test over fears that it wouldn’t pass regulatory muster.